Cervical cancer Trials in Brooklyn, United States
Conditions / Cervical cancer / Brooklyn, United States
Cervical cancer has been the subject of sustained clinical investigation across multiple research sites.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00005837 | Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer | COMPLETED | PHASE2 |
| NCT04831580 | A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer | RECRUITING | NA |
| NCT00003078 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | COMPLETED | PHASE3 |
| NCT00980954 | Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy | COMPLETED | PHASE3 |
| NCT00002562 | Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer | COMPLETED | PHASE2 |
| NCT04697628 | Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer | COMPLETED | PHASE3 |
| NCT00002478 | Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer | TERMINATED | PHASE2 |
| NCT00003369 | S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer | COMPLETED | PHASE2 |
| NCT02291055 | A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer | TERMINATED | PHASE1/PHASE2 |
| NCT03786081 | Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer | TERMINATED | — |